Helius Historical Balance Sheet
HSDT Stock | USD 1.41 0.05 3.42% |
Trend analysis of Helius Medical Technologies balance sheet accounts such as Total Current Liabilities of 1.8 M or Total Stockholder Equity of 2.9 M provides information on Helius Medical's total assets, liabilities, and equity, which is the actual value of Helius Medical Techn to its prevalent stockholders. By breaking down trends over time using Helius Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Helius Medical Techn latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Helius Medical Techn is a good buy for the upcoming year.
Helius Medical Inventory |
|
Helius |
About Helius Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Helius Medical Techn at a specified time, usually calculated after every quarter, six months, or one year. Helius Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Helius Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Helius currently owns. An asset can also be divided into two categories, current and non-current.
Helius Medical Balance Sheet Chart
Helius Medical Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Helius Medical Techn uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Helius Medical's Total Current Assets are comparatively stable compared to the past year. Other Liabilities is likely to gain to about 8.6 M in 2024, whereas Net Debt is likely to drop (5.4 M) in 2024. Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of Helius Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Helius Medical Techn books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Helius Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Helius Medical Technologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Helius Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Helius Medical Techn are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most accounts from Helius Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Helius Medical Techn current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. At this time, Helius Medical's Total Current Assets are comparatively stable compared to the past year. Other Liabilities is likely to gain to about 8.6 M in 2024, whereas Net Debt is likely to drop (5.4 M) in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Current Liabilities | 2.7M | 2.0M | 1.9M | 1.8M | Total Assets | 14.1M | 17.3M | 7.7M | 9.9M |
Helius Medical balance sheet Correlations
Click cells to compare fundamentals
Helius Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Helius Medical balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 15.1K | 24.0K | 49.1K | 269.9K | 607.9K | 577.5K | |
Total Assets | 10.3M | 6.5M | 14.1M | 17.3M | 7.7M | 9.9M | |
Total Current Liabilities | 3.8M | 2.4M | 2.7M | 2.0M | 1.9M | 1.8M | |
Total Stockholder Equity | 5.8M | 3.9M | 11.3M | 8.2M | 2.4M | 2.9M | |
Net Tangible Assets | 4.0M | 3.9M | 10.2M | 8.0M | 9.2M | 9.7M | |
Net Debt | (4.8M) | (3.2M) | (11.0M) | (14.4M) | (5.1M) | (5.4M) | |
Retained Earnings | (104.8M) | (118.9M) | (137.0M) | (151.1M) | (160.0M) | (152.0M) | |
Accounts Payable | 1.7M | 747K | 1.1M | 627K | 531K | 504.5K | |
Cash | 5.5M | 3.3M | 11.0M | 14.5M | 5.2M | 7.6M | |
Cash And Short Term Investments | 5.5M | 3.3M | 11.0M | 14.5M | 5.2M | 7.7M | |
Common Stock Total Equity | 52.2M | 26K | 31K | 1K | 900.0 | 855.0 | |
Liabilities And Stockholders Equity | 10.3M | 6.5M | 14.1M | 17.3M | 7.7M | 9.9M | |
Other Current Assets | 610K | 735K | 862K | 1.2M | 1.0M | 777.2K | |
Total Liab | 4.5M | 2.7M | 2.8M | 9.1M | 5.3M | 7.1M | |
Total Current Assets | 7.2M | 4.7M | 12.6M | 16.7M | 7.3M | 9.1M | |
Short Term Debt | 172K | 59K | 3K | 54K | 45K | 42.8K | |
Common Stock | 26K | 31K | 1K | 4K | 28K | 950.0 | |
Other Current Liab | 1.5M | 1.3M | 1.4M | 1.3M | 1.3M | 1.2M | |
Net Receivables | 574K | 230K | 251K | 343K | 637K | 401.2K | |
Non Current Liabilities Total | 710K | 252K | 193K | 7.1M | 3.5M | 2.6M | |
Capital Surpluse | 6.6M | 105.4M | 111.5M | 123.9M | 142.5M | 149.6M | |
Other Stockholder Equity | 111.5M | 123.9M | 149.4M | 159.6M | 163.0M | 91.3M | |
Accumulated Other Comprehensive Income | (902K) | (1.1M) | (1.1M) | (388K) | (673K) | (706.7K) | |
Non Current Assets Total | 3.1M | 1.9M | 1.5M | 590K | 394K | 374.3K | |
Property Plant And Equipment Net | 1.3M | 576K | 412K | 450K | 230K | 418.2K | |
Net Invested Capital | 5.8M | 3.9M | 11.3M | 8.2M | 2.4M | 2.2M | |
Property Plant And Equipment Gross | 1.3M | 576K | 412K | 450K | 589K | 631.4K | |
Net Working Capital | 3.4M | 2.3M | 9.9M | 14.7M | 5.6M | 5.8M | |
Property Plant Equipment | 1.3M | 486K | 412K | 450K | 517.5K | 612.2K | |
Inventory | 598K | 389K | 476K | 589K | 457K | 531.9K |
Pair Trading with Helius Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Helius Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helius Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Helius Stock
0.91 | CAH | Cardinal Health Fiscal Year End 20th of August 2024 | PairCorr |
Moving against Helius Stock
0.94 | WGS | GeneDx Holdings Corp | PairCorr |
0.75 | INGN | Inogen Inc | PairCorr |
0.5 | ESTA | Establishment Labs | PairCorr |
The ability to find closely correlated positions to Helius Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Helius Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Helius Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Helius Medical Technologies to buy it.
The correlation of Helius Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Helius Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Helius Medical Techn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Helius Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Helius Stock analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.22) | Revenue Per Share 1.059 | Quarterly Revenue Growth (0.53) | Return On Assets (0.61) | Return On Equity (1.69) |
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.